Companies: 10,795·Total market cap: $144.5T
Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc.

ESTANASDAQHealthcare● Active
$74.84
+$0.53(+0.71%)
Market Cap$2.2B
P/E Ratio
52W High$83.31
52W Low$33.35

Establishment Labs Holdings Inc. (ESTA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

esta · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Establishment Labs Holdings Inc. (ESTA) measures how much investors pay for each dollar of the company's trailing earnings. ESTA's current PE ratio of N/A is calculated by dividing its stock price of $74.84 by its TTM earnings per share of -$1.48.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
15022.08x
FY2027 est. EPS $0.00
Based on 4 analysts
EPS (TTM)
-$1.48
TTM · diluted EPS
PEG Ratio
-0.69
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Establishment Labs Holdings Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2016 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc.You
ESTA
$2.2BN/A-$1.48
AdaptHealth Corp.
AdaptHealth Corp.
AHCO
$1.3BN/A-$0.52
Azenta, Inc.
Azenta, Inc.
AZTA
$1.0BN/A-$1.22
CONMED Corporation
CONMED Corporation
CNMD
$1.0B26.78x$1.52
Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd.
KMTS
$1.2BN/A-$2.30
NovoCure Limited
NovoCure Limited
NVCR
$2.0BN/A-$1.22
SS Innovations International, Inc.
SS Innovations International, Inc.
SSII
$706MN/A-$0.06

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.72
2024-12-31
FY2024
$-3.00
2023-12-31
FY2023
$-3.07
2022-12-31
FY2022
$-3.08
2021-12-31
FY2021
$-1.72
2020-12-31
FY2020
$-1.63
2019-12-31
FY2019
$-1.86
2018-12-31
FY2018
$-1.22
2017-12-31
FY2017
$-2.33
2016-12-31
FY2016
$-1.20

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Establishment Labs Holdings Inc. (ESTA) measures how much investors pay for each dollar of the company's trailing earnings. ESTA's current PE ratio of N/A is calculated by dividing its stock price of $74.84 by its TTM earnings per share of -$1.48.

PE Ratio = Stock Price ÷ EPS (TTM)
= $74.84 ÷ -$1.48 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ESTA pe ratio · 6 questions

ESTA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $74.84 and TTM EPS of -$1.48. Data sourced from Financial Modeling Prep via ESTA's SEC 10-K and 10-Q filings.

ESTA PE ratioWhat is ESTA PE ratioCurrent PE ratio of ESTAESTA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Establishment Labs Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08